ANRO logo

Alto Neuroscience (ANRO)

Profile

Full Name

Alto Neuroscience

Ticker Symbol

ANRO

Exchange

NYSE

Country

United States

IPO

February 2, 2024

Indexes

Not included

Employees

76

Key Details

Price

$2.25(-4.66%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$2.50(-76.11% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 7, 25 HC Wainwright & Co.
Buy
Dec 16, 24 Jones Trading
Buy
Nov 13, 24 Stifel
Buy
Oct 23, 24 Wedbush
Neutral
Oct 23, 24 Baird
Outperform
Sep 10, 24 Wedbush
Outperform
Sep 3, 24 Wedbush
Outperform
Jun 21, 24 Rodman & Renshaw
Buy
Mar 25, 24 Stifel
Buy
Feb 27, 24 Stifel
Buy

Institutional Ownership

  • What is the ticker symbol for Alto Neuroscience?
  • Does Alto Neuroscience pay dividends?
  • What sector is Alto Neuroscience in?
  • What industry is Alto Neuroscience in?
  • What country is Alto Neuroscience based in?
  • When did Alto Neuroscience go public?
  • Is Alto Neuroscience in the S&P 500?
  • Is Alto Neuroscience in the NASDAQ 100?
  • Is Alto Neuroscience in the Dow Jones?
  • When was Alto Neuroscience's last earnings report?
  • When does Alto Neuroscience report earnings?
  • Should I buy Alto Neuroscience stock now?

What is the ticker symbol for Alto Neuroscience?

The ticker symbol for Alto Neuroscience is NYSE:ANRO

Does Alto Neuroscience pay dividends?

No, Alto Neuroscience does not pay dividends

What sector is Alto Neuroscience in?

Alto Neuroscience is in the Healthcare sector

What industry is Alto Neuroscience in?

Alto Neuroscience is in the Biotechnology industry

What country is Alto Neuroscience based in?

Alto Neuroscience is headquartered in United States

When did Alto Neuroscience go public?

Alto Neuroscience's initial public offering (IPO) was on February 2, 2024

Is Alto Neuroscience in the S&P 500?

No, Alto Neuroscience is not included in the S&P 500 index

Is Alto Neuroscience in the NASDAQ 100?

No, Alto Neuroscience is not included in the NASDAQ 100 index

Is Alto Neuroscience in the Dow Jones?

No, Alto Neuroscience is not included in the Dow Jones index

When was Alto Neuroscience's last earnings report?

Alto Neuroscience's most recent earnings report was on Mar 20, 2025

When does Alto Neuroscience report earnings?

The next expected earnings date for Alto Neuroscience is May 30, 2025

Should I buy Alto Neuroscience stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page